Avicenna Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.98M

  • Investors
  • 2

Avicenna Biosciences General Information

Description

Developer of an ML-driven medicinal chemistry platform intended to redesign and optimize drug candidates. The company utilizes ensemble-based machine learning approaches to identify new chemical entities and expand the range of challenges that can be overcome, and transform sub-optimal development candidates into life-saving drugs, and make lead optimization faster and cheaper, enabling pharmaceutical companies to reduce any deficiencies in their drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 West Chapel Hill Street
  • Suite 210
  • Durham, NC 27701
  • United States
+1 (919)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 101 West Chapel Hill Street
  • Suite 210
  • Durham, NC 27701
  • United States
+1 (919)

Avicenna Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avicenna Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 28-Oct-2025 $5.98M Completed Generating Revenue
3. Debt - General 16-Jul-2024 Completed Generating Revenue
2. Early Stage VC 23-Feb-2024 $6M $8.5M Completed Generating Revenue
1. Seed Round 14-Sep-2020 $2.5M $2.5M Completed Generating Revenue
To view Avicenna Biosciences’s complete valuation and funding history, request access »

Avicenna Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Avicenna Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Avicenna Biosciences Patents

Avicenna Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026011129-A1 Azaindole rock inhibitors for the treatment of medical disorders Pending 03-Jul-2024
WO-2026011126-A1 Azaindole rock inhibitors with advantageous properties Pending 03-Jul-2024
WO-2026011127-A1 New rock inhibitors Pending 03-Jul-2024
AU-2023415105-A1 Azaindole rock inhibitors Pending 30-Dec-2022
EP-4642764-A2 Azaindole rock inhibitors Pending 30-Dec-2022 C07D471/04
To view Avicenna Biosciences’s complete patent history, request access »

Avicenna Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avicenna Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
DCVC Bio Venture Capital Minority
DCVC Venture Capital Minority
To view Avicenna Biosciences’s complete investors history, request access »

Avicenna Biosciences FAQs

  • When was Avicenna Biosciences founded?

    Avicenna Biosciences was founded in 2020.

  • Where is Avicenna Biosciences headquartered?

    Avicenna Biosciences is headquartered in Durham, NC.

  • What is the size of Avicenna Biosciences?

    Avicenna Biosciences has 12 total employees.

  • What industry is Avicenna Biosciences in?

    Avicenna Biosciences’s primary industry is Biotechnology.

  • Is Avicenna Biosciences a private or public company?

    Avicenna Biosciences is a Private company.

  • What is Avicenna Biosciences’s current revenue?

    The current revenue for Avicenna Biosciences is .

  • How much funding has Avicenna Biosciences raised over time?

    Avicenna Biosciences has raised $20.5M.

  • Who are Avicenna Biosciences’s investors?

    DCVC Bio and DCVC have invested in Avicenna Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process